. In vivo genome editing improves motor function and extends survival in a mouse model of ALS. Sci Adv. 2017 Dec;3(12):eaar3952. Epub 2017 Dec 20 PubMed.


Please login to recommend the paper.


  1. This is an extremely important, albeit not entirely surprising, observation given the link between mutated forms of this enzyme and familial ALS. Unfortunately, gene editing is not likely to be the "Holy Grail" for persons diagnosed with sporadic ALS.

    View all comments by Marcia Ratner

Make a Comment

To make a comment you must login or register.

This paper appears in the following:


  1. Gene Editing Delays Disease Onset in ALS Model Mice